Creative Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.3M Buy
928,033
+179,268
+24% +$10.5M 0.04% 199
2025
Q4
$40.4M Buy
748,765
+225,645
+43% +$10.9M 0.03% 236
2025
Q3
$23.6M Buy
523,120
+72,927
+16% +$3.41M 0.02% 319
2025
Q2
$20.8M Sell
450,193
-95,476
-17% -$4.69M 0.02% 328
2025
Q1
$33.3M Buy
545,669
+27,890
+5% +$1.63M 0.03% 224
2024
Q4
$29.3M Buy
517,779
+26,996
+6% +$1.51M 0.03% 226
2024
Q3
$25.4M Sell
490,783
-41,187
-8% -$1.93M 0.03% 236
2024
Q2
$22.1M Buy
531,970
+149,088
+39% +$6.67M 0.02% 245
2024
Q1
$20.8M Buy
382,882
+40,960
+12% +$2.09M 0.02% 255
2023
Q4
$17.5M Sell
341,922
-21,110
-6% -$1.11M 0.03% 268
2023
Q3
$21.1M Buy
363,032
+18,243
+5% +$1.12M 0.03% 232
2023
Q2
$22M Buy
344,789
+18,214
+6% +$1.22M 0.03% 207
2023
Q1
$22.6M Sell
326,575
-3,826
-1% -$270K 0.03% 198
2022
Q4
$23.8M Buy
330,401
+17,705
+6% +$1.33M 0.04% 188
2022
Q3
$22.2M Buy
312,696
+3,090
+1% +$224K 0.04% 173
2022
Q2
$23.8M Buy
309,606
+40,506
+15% +$3.08M 0.04% 179
2022
Q1
$19.7M Buy
269,100
+6,647
+3% +$446K 0.03% 206
2021
Q4
$16.4M Sell
262,453
-8,276
-3% -$485K 0.03% 208
2021
Q3
$16M Sell
270,729
-4,098
-1% -$270K 0.03% 202
2021
Q2
$18.4M Sell
274,827
-62,457
-19% -$4.07M 0.03% 183
2021
Q1
$21.3M Sell
337,284
-2,311
-0.7% -$144K 0.04% 167
2020
Q4
$21.1M Buy
339,595
+15,220
+5% +$936K 0.05% 157
2020
Q3
$19.6M Buy
324,375
+19,276
+6% +$1.16M 0.05% 137
2020
Q2
$17.9M Buy
305,099
+411
+0.1% +$24.6K 0.05% 132
2020
Q1
$17M Sell
304,688
-19,706
-6% -$1.2M 0.06% 120
2019
Q4
$20.8M Buy
324,394
+41,139
+15% +$2.36M 0.06% 121
2019
Q3
$14.4M Buy
283,255
+331
+0.1% +$15.6K 0.05% 139
2019
Q2
$12.8M Sell
282,924
-4,217
-1% -$196K 0.04% 150
2019
Q1
$13.7M Sell
287,141
-8,319
-3% -$414K 0.05% 131
2018
Q4
$15.4M Sell
295,460
-265
-0.1% -$14.2K 0.06% 117
2018
Q3
$18.4M Buy
295,725
+16,361
+6% +$971K 0.07% 106
2018
Q2
$15.5M Sell
279,364
-10,126
-3% -$547K 0.06% 116
2018
Q1
$18.3M Sell
289,490
-13,135
-4% -$845K 0.07% 95
2017
Q4
$18.5M Buy
302,625
+32,141
+12% +$2.01M 0.08% 93
2017
Q3
$17.2M Sell
270,484
-23,678
-8% -$1.38M 0.08% 104
2017
Q2
$16.4M Buy
294,162
+3,099
+1% +$169K 0.08% 98
2017
Q1
$15.8M Sell
291,063
-33,956
-10% -$1.86M 0.09% 92
2016
Q4
$19M Sell
325,019
-1,500
-0.5% -$82K 0.12% 87
2016
Q3
$17.6M Buy
326,519
+42,990
+15% +$2.76M 0.11% 88
2016
Q2
$20.9M Buy
283,529
+10,554
+4% +$746K 0.15% 66
2016
Q1
$17.4M Sell
272,975
-2,475
-0.9% -$156K 0.14% 72
2015
Q4
$18.9M Buy
275,450
+21,993
+9% +$1.45M 0.16% 72
2015
Q3
$15M Buy
253,457
+60,527
+31% +$3.84M 0.13% 78
2015
Q2
$12.8M Buy
192,930
+9,734
+5% +$641K 0.12% 85
2015
Q1
$11.8M Buy
183,196
+16,639
+10% +$1.04M 0.11% 84
2014
Q4
$9.83M Buy
166,557
+20,603
+14% +$1.16M 0.1% 94
2014
Q3
$7.47M Buy
145,954
+10,446
+8% +$522K 0.09% 103
2014
Q2
$6.57M Buy
135,508
+6,326
+5% +$312K 0.09% 103
2014
Q1
$6.71M Sell
129,182
-2,197
-2% -$117K 0.1% 93
2013
Q4
$6.98M Buy
131,379
+11,440
+10% +$583K 0.12% 84
2013
Q3
$5.55M Buy
119,939
+19,239
+19% +$845K 0.11% 80
2013
Q2
$4.5M Buy
+100,700
New +$4.37M 0.1% 83

Other funds holding BMY

Creative Planning's BMY Position: Q1 2026 in Review

Creative Planning increased its Bristol-Myers Squibb (BMY) stake by 24% in Q1 2026, buying an estimated $10.5M and bringing the position to 928,033 shares worth $56.3M. The position accounts for 0.04% of the portfolio, ranked #199.

Creative Planning first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Creative Planning held 928,033 shares of Bristol-Myers Squibb worth $56.3M as of Q1 2026.
  • Creative Planning bought 179,268 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.5M.
  • Bristol-Myers Squibb made up 0.04% of Creative Planning's portfolio in Q1 2026, its #199 holding.
  • Creative Planning first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.